Keyphrases
Radiation Therapy
61%
Radiotherapy
60%
Radiation Oncology
46%
United States
42%
Brain Tumor Patients
35%
Sexual Dysfunction
35%
Radiation Oncologist
34%
Industry Payments
31%
Pelvic Radiotherapy
27%
Primary Brain Tumor
26%
Female Patients
24%
Stereotactic Radiosurgery
21%
Medical Oncologist
21%
Prospective Clinical Trial
20%
Confidence Interval
20%
Odds Ratio
19%
Older Patients
19%
Retrospective Analysis
19%
Dose Effect
18%
Sexual Behavior
18%
Brain Radiotherapy
17%
Scoping Review
17%
Health-related Quality of Life
17%
Open Payments Program
17%
Medical Malpractice
17%
U.S. Food
17%
Oncologists
17%
Executive Function
17%
Post-irradiation
16%
Three-dimensional Conformal Radiotherapy
16%
General Payments
16%
Ownership Interest
16%
Oncology
15%
Overall Survival
14%
Head-and-neck Cancer
14%
Brain Metastases
14%
Brachytherapy
14%
Cancer Care
13%
Open Payments
13%
High-grade Glioma
12%
Indemnity Payments
12%
Mean Diffusivity
12%
Multivariable
12%
Financial Relations
12%
Sexual Health
12%
Closed Claims
11%
Trauma-informed Care
11%
Cancer Treatment
11%
Non-small Cell Lung Cancer (NSCLC)
11%
Fractional Anisotropy
11%
Medicine and Dentistry
Radiation Therapy
100%
Radiation Oncology
45%
Malignant Neoplasm
45%
Radiation Oncologist
33%
Pelvic Radiotherapy
31%
Oncologist
31%
Intensity Modulated Radiation Therapy
26%
Injury
26%
Medicare
25%
Brain Metastasis
22%
Neoplasm
18%
Odds Ratio
18%
Head and Neck Cancer
17%
Stereotactic Body Radiation Therapy
17%
Non Small Cell Lung Cancer
17%
Medical Device
17%
Pelvis
17%
Quality of Life
16%
Side Effect
16%
Cardiovascular System
16%
Conformal Radiotherapy
16%
Brachytherapy
15%
Overall Survival
15%
Patient Care
14%
Stereotactic Radiosurgery
14%
Anus
13%
Radiation Treatment Planning
11%
Breast Cancer
11%
Transgender
10%
Systematic Review
10%
Brain Tumor
10%
Opiate
10%
Disease
10%
Hazard Ratio
9%
Health Care Cost
9%
Treatment Planning
9%
Neck
9%
Oncology
9%
Cancer Therapy
9%
Neutrophil
8%
Treatment Interruption
8%
Bone Metastasis
8%
Hemispheric Dominance
8%
Anatomy
8%
Cannabis
8%
Prognostic Assessment
8%
Pathologist
8%
Cerebral Cortex
8%
High-Dose-Rate Brachytherapy
8%
Squamous Cell Carcinoma
8%
